DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Amgen 

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax Corp.  Antibody phage display





 Company News
Amgen (AMGN) Thyroid Drug AMG 416 Succeeds In Late Stage Kidney Patient Trial 7/17/2014 3:58:30 PM
That Model Genentech (RHHBY), Gilead Sciences, Inc. (GILD), And Amgen (AMGN) Were Built On—Does It Work Anymore? 7/16/2014 6:15:13 AM
Amgen (AMGN) Spinoff Atara Biotherapeutics Hikes IPO Target From $50 Million To $92 Million 7/11/2014 8:16:49 AM
BIND Therapeutics (BIND) Ends Cancer Drug Pact With Amgen (AMGN); BIND Stock Down -10.02% At Market Close (July 3, 2014) 7/3/2014 7:57:44 AM
Bellerophon Therapeutics Brings In Ex-Amgen (AMGN) Exec For CEO Post 7/2/2014 7:52:47 AM
Amgen (AMGN) Wins FDA Breakthrough Therapy Designation For Investigational BiTE 7/1/2014 6:28:49 AM
Amgen (AMGN) Joins The National Cancer Institute And Research Partners To Help Accelerate Development Of Personalized Treatment Approaches For Squamous Cell Lung Cancer 6/17/2014 9:59:39 AM
Amgen (AMGN)'s Psoriatic Arthritis Drug Brodalumab Maintains Efficacy After One Year Study 6/12/2014 6:36:59 AM
Amgen (AMGN) Brings In Ex-3M Company (MMM) CFO Meline As Finance Chief 6/9/2014 4:27:28 PM
Amgen (AMGN) To Present At The Goldman, Sachs & Co. Global Healthcare Conference 6/9/2014 10:03:11 AM
12345678910...